Sequana Medical Launches Belgian IPO

Sequana Medical has launched an IPO on Euronext Brussels a few days after the US FDA granted a breakthrough device designation to Sequana’s alfapump for liver ascites. 

MT1902_Breakthrough_1270750687_1200.jpg
• Source: shutterstock.com

Sequana Medical AG has launched an IPO on Euronext Brussels, seeking to raise between €27.5m and €38.5m ($31.5m - $44.1m).

The company is pricing over 3.2 million shares at between €8.50 and €9.00 each. The middle of the price range will give Sequana Medical a market capitalization of €119.5m ($137m).

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business